Prescription trends of PCSK9 inhibitors in Hong Kong

被引：0
|
作者：
Yu, Qiuyan [1 ]
Chui, Celine Sze Ling [2 ]
Ma, Tiantian [1 ]
机构：
[1] Univ Hong Kong, Dept Pharmacol & Pharm, Hong Kong, Peoples R China
[2] Univ Hong Kong, Hong Kong, Peoples R China
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2023年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
1234
引用
收藏
页码：583 / 583
页数：1
相关论文
共 50 条
  • [1] PCSK9 inhibitors on blue prescription for whom?
    Semb, Anne Grete
    Vesterbekkmo, Elisabeth Kleivhaug
    Retterstol, Kjetil
    Atar, Dan
    Solberg, Erik E.
    Schirmer, Henrik
    Lochen, Maja-Lisa
    Kask, Anne
    Grimsmo, Jostein
    Ingul, Charlotte Bjork
    Munkhaugen, John
    [J]. TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING, 2023, 143 (08) : 680 - 682
  • [2] PCSK9 inhibitors
    Farnier, Michel
    [J]. CORRESPONDANCES EN METABOLISMES HORMONES DIABETES ET NUTRITION, 2015, 19 (03): : 66 - 70
  • [3] PCSK9 inhibitors
    Farnier, Michel
    [J]. CURRENT OPINION IN LIPIDOLOGY, 2013, 24 (03) : 251 - 258
  • [4] PCSK9 inhibitors
    Gencer, Baris
    Lambert, Gilles
    Mach, Francois
    [J]. SWISS MEDICAL WEEKLY, 2015, 145
  • [5] Characteristics and trends of PCSK9 inhibitor prescription fills in the United States
    Attipoe-Dorcoo, Sharon
    Yang, Peter
    Sperling, Laurence
    Loustalot, Fleetwood
    Thompson-Paul, Angela M.
    Gray, Elizabeth B.
    Park, Soyoun
    Ritchey, Matthew D.
    [J]. JOURNAL OF CLINICAL LIPIDOLOGY, 2021, 15 (02) : 332 - 338
  • [6] Safety of PCSK9 inhibitors
    Grzesk, Grzegorz
    Dorota, Bednarska
    Wolowiec, Lukasz
    Wolowiec, Anna
    Osiak, Joanna
    Kozakiewicz, Mariusz
    Banach, Joanna
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2022, 156
  • [7] Access to PCSK9 Inhibitors
    Baum, Seth J.
    Lepor, Norman E.
    Robinson, Jennifer G.
    [J]. REVIEWS IN CARDIOVASCULAR MEDICINE, 2018, 19 : S47 - S50
  • [8] PCSK9 inhibitors are go
    Mullard, Asher
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2015, 14 (09) : 593 - 593
  • [9] Oral PCSK9 Inhibitors
    Anandita Agarwala
    Ramsha Asim
    Christie M. Ballantyne
    [J]. Current Atherosclerosis Reports, 2024, 26 : 147 - 152
  • [10] PCSK9 inhibitors are go
    Asher Mullard
    [J]. Nature Reviews Drug Discovery, 2015, 14 : 593 - 593
12345